Anticoagulant therapy in patients w ith atrial fibrillation:safety and compliance
10.3760/cma.j.issn.1673-4165.2016.01.012
- VernacularTitle:心房颤动患者卒中预防中的抗凝治疗：安全性和依从性
- Author:
Jieling SHEN
;
Xinjiang ZHANG
;
Lihong TAO
;
Tieyu TANG
- Publication Type:Journal Article
- Keywords:
Atrial Fibril ation;
Stroke;
Brain Ischemia;
Anticoagulants;
Patient Compliance
- From:
International Journal of Cerebrovascular Diseases
2016;24(1):68-74
- CountryChina
- Language:Chinese
-
Abstract:
The most important harms of atrial fibrilation are stroke and the embolic events of the systemic circulation. The latest data have show n that the etiology of up to 1/3 of stroke patients w as atrial fibrilation. The stroke morbidity and mortality caused by atrial fibrilation are higher than other types of stroke. So the prevention of stroke is very important for patients with atrial fibrilation. The anticoagulant therapy is the core strategy for stroke prevention in patients with atrial fibrilation. This article reviews the advances in research on the safety and compliance of anticoagulation therapy in patients w ith atrial fibrilation.
